Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 30 of 72 results for diabetic foot

  1. How often should people with diabetic foot problems (foot ulcers, soft tissue infections, osteomyelitis or gangrene) be reviewed?

    ID NG19/8 Question How often should people with diabetic foot problems (foot ulcers, soft tissue infections, osteomyelitis...

    Research recommendation
    Published
    18 November 2019

  2. What is the clinical effectiveness of different dressing types in treating diabetic foot problems?

    is the clinical effectiveness of different dressing types in treating diabetic foot problems? Any explanatory notes(if applicable) Source

    Research recommendation
    Published
    15 November 2019

  3. What is the clinical effectiveness of maggot debridement therapy in the debridement of diabetic foot ulcers?

    clinical effectiveness of maggot debridement therapy in the debridement of diabetic foot ulcers? Any explanatory notes(if applicable)...

    Research recommendation
    Published
    18 November 2019

  4. What is the clinical effectiveness of negative pressure wound therapy in the treatment of diabetic foot ulcers?

    effectiveness of negative pressure wound therapy in the treatment of diabetic foot ulcers? Any explanatory notes(if applicable) Source

    Research recommendation
    Published
    18 November 2019

  5. What is the role of educational models and psycho-behavioural interventions in prevention of diabetic foot complications?

    educational models and psycho-behavioural interventions in prevention of diabetic foot complications? Any explanatory notes(if...

    Research recommendation
    Published
    15 November 2019

  6. Granulox for managing chronic non-healing wounds (MIB296)

    NICE has developed a medtech innovation briefing (MIB) on Granulox for managing chronic non-healing wounds .

    Medtech innovation briefing
    Published
    10 May 2022

  7. EpiFix for chronic wounds (MIB139)

    NICE has developed a medtech innovation briefing (MIB) on EpiFix for chronic wounds .

    Medtech innovation briefing
    Published
    30 January 2018

  8. Education and psycho-behavioural interventions for prevention:- What is the role of educational models and psycho-behavioural interventions in prevention of diabetic foot complications?

    educational models and psycho-behavioural interventions in prevention of diabetic foot complications? Any explanatory notes(if...

    Research recommendation
    Published
    12 October 2015

  9. Improving foot care outcomes for people with diabetes in Wessex

    clinicians, operational managers, commissioners and patients. The Wessex Foot Care standards were jointly developed and agreed by local...

    Shared learning
    Published
    22 March 2019

  10. Does intensive monitoring of people at risk of diabetic foot disease reduce the morbidity associated with developing the disease and is such monitoring cost effective?

    NG19/1 Question Does intensive monitoring of people at risk of diabetic foot disease reduce the morbidity associated with developing the...

    Research recommendation
    Published
    15 November 2019

  11. LQD Spray for treating acute and chronic wounds (MIB202)

    NICE has developed a medtech innovation briefing (MIB) on LQD Spray for treating acute and chronic wounds .

    Medtech innovation briefing
    Published
    17 December 2019

  12. The Debrisoft monofilament debridement pad for use in acute or chronic wounds (MTG17)

    Evidence-based recommendations on the Debrisoft monofilament debridement pad for use in acute or chronic wounds.

    Medical technologies guidance
    Last updated
    25 March 2019
    View recommendations

    Sections for MTG17

  13. Type 1 diabetes in adults: diagnosis and management (NG17)

    This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.

    NICE guideline
    Last updated
    17 August 2022
    View recommendations

    Sections for NG17

  14. NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds

      Status ...

    Medical technologies guidance
    Topic selection

  15. Woundchek Protease Status for assessing elevated protease status in chronic wounds (MIB83)

    NICE has developed a medtech innovation briefing (MIB) on the Woundchek Protease Status for assessing elevated protease status in chronic wounds .

    Medtech innovation briefing
    Published
    5 October 2016